Home » Newsletters » BioWorld Science

BioWorld Science

April 12, 2013

View Archived Issues

Novel LM-Kras vaccine delays progression of pancreatic intraepithelial neoplasia in vivo

Potential new treatment for patients susceptible to lactic acidosis

Novel protein Wnt signaling inhibitors synthesized at Samumed

Development of novel ERK inhibitor SCH-772984 reported

Bayer presents BAY-ACC001 as a potent and selective AAC inhibitor

AstraZeneca reports on novel ATR inhibitor AZD-6738

New protein kinase inhibitors designed by Merck KGaA

Sanofi develops novel DGAT1 inhibitors for metabolic disorders

GR modulators show promise in models of respiratory diseases

Abbott obtains CE mark for galectin-3 heart failure test

Johns Hopkins University patents new chymase inhibitors

Sanofi Pasteur's quadrivalent influenza vaccine accepted for review in Europe

Quest Diagnostics launches new tests for rheumatoid arthritis

VereFlu detects current H7N9 avian flu subtype

Sarepta Therapeutics and UWA expand agreement for exon-skipping program

Lundbeck designs novel mGlu5 receptor allosteric modulators

Avioq launches Avioq HTLV-I/II test in Europe

Photocure reports final results from phase IIb study of Cevira

Gamida Cell reports results from final analyses of phase II/III study of StemEx

Novel NS5B inhibitors disclosed by Biota Scientific Management

Confirmatory phase III study not required for filing pimavanserin NDA

New CDK9/cyclin-T1 inhibitors divulged by Bayer Intellectual Property

Sarah Cannon Research Institute to conduct phase II study of OGX-427

First European launch for Jetrea in U.K.

Aptalis launches Pylera in France

FDA accepts Varisolve NDA for full review

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...